Jan 26 (Reuters) - Mauna Kea Technologies SAS MKEA.PA :
* MAUNA KEA TECHNOLOGIES ANNOUNCES SALES FOR Q4 AND FULL
YEAR 2022
* Q4 AND FULL YEAR 2022 SALES IN LINE WITH EXPECTATIONS AT
EUR 2.7
MILLION AND EUR 7.5 MILLION, RESPECTIVELY
* U.S. LEVEL OF SALES STABLE IN 2022 AT EUR 4.2 MILLION
DESPITE A
60% REDUCTION IN SALES PERSONNEL FOLLOWING STRATEGIC REALIGNMENT
* AS OF DECEMBER 31, 2022, COMPANY'S CASH POSITION AMOUNTED
TO EUR
3.2 MILLION
* COMPANY WILL RECEIVE BALANCE OF $3.5 MILLION IN COMING
MONTHS,
AS PART OF ITS AGREEMENT WITH TASLY PHARMACEUTICAL
Source text for Eikon: ID:nBw3zk3D4a
Further company coverage: MKEA.PA
(Gdansk Newsroom)
((gdansk.newsroom@thomsonreuters.com; +48587696600;))